Search results
John Sapp
Job title: Clinical Cardiac Electrophysiologist
Author
Jeffrey J Goldberger
Author
Richard Whitlock
Author
Juan C. Lopez-Mattei
Research Area(s) / Expertise:
Job title: Associate Professor, Cardiology and Diagnostic Imaging, MD Anderson Cancer Center, University of Texas, Houston, US
Author
Payal Kohli
Research Area(s) / Expertise:
Job title: Associate Adjunct Professor in Cardiology
Author
Added:
2 months ago
Source:
Radcliffe CVRM
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are known to reduce major atherosclerotic cardiovascular events, but the full extent of their mechanisms is still being explored. The SEMA-VR CardioLink-15 trial investigated whether semaglutide affects the levels of circulating vascular regenerative (VR) cells, which are involved in vessel repair and may modulate atherothrombotic risk.¹…
View more
Kashish Goel
Job title: Advanced Structural/interventional fellow
Author
Pugazhendhi Vijayaraman
Author
Sanjay Kaul
Job title: Professor of Medicine
Author
Verena Veulemans
Job title: Interventional cardiologist
Author